Kinnate Biopharma

+$0.24 (+1.02%) Today
$0.00 (0.00%) As of 8:01 PM UTC after-hours

Why Robinhood?

You can buy or sell KNTE and other stocks, options, and ETFs commission-free!

About KNTE

Kinnate Biopharma, Inc. operates as a biopharmaceutical company, which engages in the research and development of Kinnate Discovery Engine that targets genomic drivers of cancer. The company was founded by Stephen W.

CEO
Nima M. Farzan
Employees
31
Headquarters
San Diego, California
Founded
2018

KNTE Key Statistics

Market Cap
1.04B
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
121.51K
High Today
$24.30
Low Today
$22.78
Open Price
$23.50
Volume
128.06K
52 Week High
$48.75
52 Week Low
$21.27

KNTE Earnings

-$0.40
-$0.27
-$0.13
$0.00
Q4 FY20
Q1 FY21
Q2 FY21
Estimated
— per share
Actual
Expected Aug 6, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure